Development and initial validation of a self-assessed lupus organ damage instrument
- PMID: 20391512
- PMCID: PMC3179258
- DOI: 10.1002/acr.20193
Development and initial validation of a self-assessed lupus organ damage instrument
Abstract
Objective: The Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI) is a validated instrument for assessing organ damage in systemic lupus erythematosus (SLE). Trained physicians must complete it, thus limiting utility where this is impossible.
Methods: We developed and pilot tested a self-assessed organ damage instrument, the Lupus Damage Index Questionnaire (LDIQ), in 37 SLE subjects and 7 physicians. After refinement, 569 English-speaking SLE subjects and 14 rheumatologists from 11 international SLE clinics participated in validation. Subjects and physicians completed the instruments separately. We calculated sensitivity, specificity, Spearman's correlations, and agreement using the SDI as the gold standard. Six hundred five SLE participants in the community-based National Data Bank for Rheumatic Diseases (NDB) study completed the LDIQ and we assessed correlations with outcome and disability measures.
Results: The mean LDIQ score was 3.3 (range 0-16) and the mean SDI score was 1.5 (range 0-9). The LDIQ had a moderately high correlation with the SDI (Spearman's r = 0.50, P < 0.001). Specificities of individual LDIQ items were >80%, except for neuropathy. Sensitivities were variable and lowest for damage, with <1% prevalence. Agreement between the SDI and LDIQ was >85% for all but neuropathy, reduced renal function, deforming arthritis, and alopecia. In the NDB, the LDIQ correlated well with the comorbidity index (r = 0.45), the Short Form 36 physical component scale (r = 0.43), the Medical Research Council dyspnea scale (r = 0.40), disability (r = 0.37), and the Systemic Lupus Erythematosus Activity Questionnaire score (r = 0.37).
Conclusion: The metric properties of the LDIQ are good compared with the SDI. It has construct validity and correlations with health assessments similar to the SDI. The LDIQ should allow expansion of SLE research. Its ultimate value will be determined in longitudinal studies.
Figures
Similar articles
-
Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort.Arthritis Care Res (Hoboken). 2014 Jun;66(6):888-96. doi: 10.1002/acr.22231. Arthritis Care Res (Hoboken). 2014. PMID: 24249662 Free PMC article.
-
Validation of the Japanese version of the Lupus Damage Index Questionnaire in a large observational cohort: A two-year prospective study.Mod Rheumatol. 2021 Jul;31(4):834-842. doi: 10.1080/14397595.2020.1829341. Epub 2020 Oct 13. Mod Rheumatol. 2021. PMID: 32990111
-
Brief index of lupus damage: a patient-reported measure of damage in systemic lupus erythematosus.Arthritis Care Res (Hoboken). 2011 Aug;63(8):1170-7. doi: 10.1002/acr.20503. Arthritis Care Res (Hoboken). 2011. PMID: 21584946 Free PMC article.
-
Indices to assess patients with systemic lupus erythematosus in clinical trials, long-term observational studies, and clinical care.Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-85-95. Epub 2014 Oct 30. Clin Exp Rheumatol. 2014. PMID: 25365095 Review.
-
Measuring Disease Damage and Its Severity in Childhood-Onset Systemic Lupus Erythematosus.Arthritis Care Res (Hoboken). 2018 Nov;70(11):1621-1629. doi: 10.1002/acr.23531. Arthritis Care Res (Hoboken). 2018. PMID: 29409150
Cited by
-
Racial Discrimination, Disease Activity, and Organ Damage: The Black Women's Experiences Living With Lupus (BeWELL) Study.Am J Epidemiol. 2019 Aug 1;188(8):1434-1443. doi: 10.1093/aje/kwz105. Am J Epidemiol. 2019. PMID: 31062841 Free PMC article.
-
Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).Arthritis Care Res (Hoboken). 2011 Nov;63 Suppl 11(0 11):S37-46. doi: 10.1002/acr.20572. Arthritis Care Res (Hoboken). 2011. PMID: 22588757 Free PMC article. Review. No abstract available.
-
[Possibilities and limits of patient-reported outcome exemplified by systemic lupus erythematosus and the LuLa study].Z Rheumatol. 2014 Oct;73(8):698-705. doi: 10.1007/s00393-014-1412-1. Z Rheumatol. 2014. PMID: 25260816 German.
-
To what extent can preventive treatments prevent damage from systemic lupus erythematosus?Curr Rheumatol Rep. 2011 Aug;13(4):317-23. doi: 10.1007/s11926-011-0188-4. Curr Rheumatol Rep. 2011. PMID: 21611806 Review.
-
Validity of a self-administered version of the brief index of lupus damage in a predominantly African American systemic lupus erythematosus cohort.Arthritis Care Res (Hoboken). 2014 Jun;66(6):888-96. doi: 10.1002/acr.22231. Arthritis Care Res (Hoboken). 2014. PMID: 24249662 Free PMC article.
References
-
- Ward MM, Pyun E, Studenski S. Long-term survival in systemic lupus erythematosus. Patient characteristics associated with poorer outcomes. Arthritis Rheum. 1995;38(2):274–83. - PubMed
-
- Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA, Jr., Jansen-McWilliams L, D’Agostino RB, Kuller LH. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. AmJEpidemiol. 1997;145(5):408–15. - PubMed
-
- Bultink IE, Lems WF, Kostense PJ, Dijkmans BA, Voskuyl AE. Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum. 2005;52(7):2044–50. - PubMed
-
- Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Mejia JC, Aydintug AO, Chwalinska-Sadowska H, de Ramon E, Fernandez-Nebro A, Galeazzi M, Valen M, Mathieu A, Houssiau F, Caro N, Alba P, Ramos-Casals M, Ingelmo M, Hughes GR. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82(5):299–308. - PubMed
-
- Gladman D, Ginzler E, Goldsmith C, Fortin P, Liang M, Urowitz M, Bacon P, Bombardieri S, Hanly J, Hay E. Systemic lupus international collaborative clinics: development of a damage index in systemic lupus erythematosus. JRheumatol. 1992;19(11):1820–1. - PubMed
Publication types
MeSH terms
Grants and funding
- F32 AR054278/AR/NIAMS NIH HHS/United States
- CAPMC/ CIHR/Canada
- K24 AR002213/AR/NIAMS NIH HHS/United States
- P60 AR047782/AR/NIAMS NIH HHS/United States
- F32-AR054278-01A1/AR/NIAMS NIH HHS/United States
- P01-AR49084/AR/NIAMS NIH HHS/United States
- P01 AR049084/AR/NIAMS NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- UL1-RR-025005/RR/NCRR NIH HHS/United States
- K24-AR002213-05/AR/NIAMS NIH HHS/United States
- R01 AR043727/AR/NIAMS NIH HHS/United States
- R01 AR049880/AR/NIAMS NIH HHS/United States
- K24-AR052401/AR/NIAMS NIH HHS/United States
- R01-AR49880/AR/NIAMS NIH HHS/United States
- HD051959/HD/NICHD NIH HHS/United States
- AR43727/AR/NIAMS NIH HHS/United States
- K12 HD051959/HD/NICHD NIH HHS/United States
- P60-AR047782/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical